Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sujiang Zhang

9PUBLICATIONS

8CO-AUTHORS

Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology not elsewhere classifiedHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Oct 31, 2025

Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera.

Shanshan Suo, Rongfeng Fu, Albert Qin

|Apr 15, 2025

Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.

Zhi-Yin Liu, Ze-Ying Yan, Jian-Feng Li

|Oct 27, 2024

Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b.

Shanshan Suo, Rong Feng Fu, Albert Qin

|Jun 19, 2024

<i>PICALM::MLLT10</i> may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax.

Haimin Sun, Yongmei Zhu, Jianfeng Li

|May 14, 2024

The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients.

Jie Tian, Yongmei Zhu, Jianfeng Li

|Jan 23, 2024

CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.

Haimin Sun, Yongmei Zhu, Jianfeng Li

Pageof 2

Frequent Collaborators

2 joint publications

Albert Qin

2 joint publications

Minghui Duan

1 joint publications

Yongmei Zhu

1 joint publications

Rong Feng Fu

1 joint publications

Jie Bai

1 joint publications

Xin Du

1 joint publications

Lei Zhang

1 joint publications

Suning Chen

Frequent Collaborators

2 joint publications

Albert Qin

2 joint publications

Minghui Duan

1 joint publications

Yongmei Zhu

1 joint publications

Rong Feng Fu

Top Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on : Jan 25, 2015

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos

Top Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on : Jan 25, 2015

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos